共查询到20条相似文献,搜索用时 15 毫秒
1.
Primary treatment for oropharyngeal squamous cell carcinoma in Alberta,Canada: A population‐based study 下载免费PDF全文
Amy J. Hobbs RN MSc Nigel T. Brockton PhD T. Wayne Matthews MD Shamir P. Chandarana MD MSc Pinaki Bose PhD Kelly Guggisberg MD Gordon H. Fick PhD Joseph C. Dort MD MSc 《Head & neck》2017,39(11):2187-2199
2.
Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas 下载免费PDF全文
Antoine E. Melkane MD Anne Auperin MD Patrick Saulnier PhD Ludovic Lacroix PharmD PhD Philippe Vielh MD PhD Odile Casiraghi MD Issam Msakni MD Françoise Drusch Stéphane Temam MD PhD 《Head & neck》2014,36(2):257-265
3.
Chen J Pappas L Moeller JH Rankin J Sharma PK Bentz BG Fang LC Hayes JK Shrieve DC Hitchcock YJ 《Head & neck》2007,29(4):362-369
BACKGROUND: We reviewed the outcomes of oropharyngeal squamous cell carcinoma treated with external beam radiation and interstitial brachytherapy. METHODS: Ninety patients with squamous cell carcinoma of the oropharynx were treated with interstitial brachytherapy at the University of Utah between 1984 and 2001. Seventy-two patients received external beam radiotherapy (EBRT) followed by brachytherapy boost, 11 had surgery followed by EBRT and brachytherapy, 4 had surgery and brachytherapy, and 3 were treated with brachytherapy alone. Median doses for EBRT and brachytherapy were 50 and 24 Gy, respectively. RESULTS: Median follow-up after brachytherapy was 48.3 months for all patients. Five-year local control, disease-free survival, and overall survival were 76%, 61%, and 55%. For T1, T2, T3, and T4, 5-year local control rates were 83%, 79%, 79%, and 64%, respectively. Severe complications occurred in 13 patients, including 2 treatment-related deaths. CONCLUSIONS: EBRT combined with interstitial brachytherapy provide good local control rates for locally advanced oropharyngeal squamous cell carcinoma. 相似文献
4.
5.
Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes 下载免费PDF全文
Bhavna Kumar MS Michael J. Cipolla MD Matthew O. Old MD Nicole V. Brown MS Stephen Y. Kang MD Peter T. Dziegielewski MD Kasim Durmus MD Enver Ozer MD Amit Agrawal MD Ricardo L. Carrau MD David E. Schuller MD Marino E. Leon MD Quintin Pan PhD Pawan Kumar PhD Valerie Wood MD Jessica Burgers MD Paul E. Wakely MD Jr Theodoros N. Teknos MD 《Head & neck》2016,38(Z1):E1794-E1802
6.
7.
Oncologic outcomes of surgically treated early‐stage oropharyngeal squamous cell carcinoma 下载免费PDF全文
Jason I. Kass MD PhD Laureano Giraldez MD William Gooding MS Garret Choby MD Seungwon Kim MD Brett Miles MD DDS Marita Teng MD Andrew G. Sikora MD PhD Jonas T. Johnson MD Eugene N. Myers MD Umamaheswar Duvvuri MD PhD Eric M. Genden MD Robert L. Ferris MD PhD 《Head & neck》2016,38(10):1467-1471
8.
Improving outcomes in veterans with oropharyngeal squamous cell carcinoma through implementation of a multidisciplinary clinic 下载免费PDF全文
Tyler Light BS Edward El Rassi MD Ronald J. Maggiore MD John Holland MD Julie Reed RN Kathleen Suriano CCC‐SLP Marcelle Stooksbury RD Nora Tobin MD Neil Gross MD Daniel Clayburgh MD PhD 《Head & neck》2017,39(6):1106-1112
9.
Recent studies of oropharyngeal carcinoma have reported remarkable correlation between integrated human papillomavirus (HPV) viral detection and p16 protein overexpression in tumor cells. These findings led to calls for the substitution of p16 expression for the more demanding HPV testing in clinical practice. The rationale for such practice is largely driven by the simplicity, low cost, and the feasibility of the immunohistochemical (IHC) analysis. There are, however, several caveats that need to be fully considered. These include the subjective nature of IHC evaluation, the variable mechanisms of p16 expression in head and neck squamous cell carcinoma, and the lack of scoring and interpretive criteria. This perspective addresses the conceptual and practical issues associated with the p16 expression analysis and provides a broad outline for its application and evaluation in patients with oropharyngeal carcinoma. 相似文献
10.
Association of impaired renal function and poor prognosis in oropharyngeal squamous cell carcinoma 下载免费PDF全文
Akihiro Homma MD Ryuichi Hayashi MD Kazuyoshi Kawabata MD Takashi Fujii MD Shigemichi Iwae MD Yasuhisa Hasegawa MD Kenichi Nibu MD Takakuni Kato MD Kiyoto Shiga MD Kazuto Matsuura MD Nobuya Monden MD Masato Fujii MD 《Head & neck》2016,38(10):1495-1500
11.
Impact of positive margins on outcomes of oropharyngeal squamous cell carcinoma according to p16 status 下载免费PDF全文
Peter Molony MB MRCPI Natallia Kharytaniuk MB Seamus Boyle MB Robbie S. R. Woods MB MRCSI Gerard O'Leary MB FRCSI Reiltin Werner MSc Cynthia Heffron MB MRCPath Linda Feeley MB MRCPath Patrick Sheahan MB FRCSI 《Head & neck》2017,39(8):1680-1688
12.
13.
14.
Best SR Ha PK Blanco RG Saunders JR Zinreich ES Levine MA Pai SI Walker M Trachta J Ulmer K Murakami P Thompson R Califano JA Messing BP 《Head & neck》2011,33(12):1727-1734
15.
Matthew E. Spector MD K. Kelly Gallagher MD Emily Light MS Mohannad Ibrahim MD Eric J. Chanowski BS Jeffrey S. Moyer MD Mark E. Prince MD Gregory T. Wolf MD Carol R. Bradford MD Kitrina Cordell DDS MS Jonathan B. McHugh MD Thomas Carey PhD Francis P. Worden MD Avraham Eisbruch MD Douglas B. Chepeha MD MSPH 《Head & neck》2012,34(12):1727-1733
16.
17.
18.
19.
Retrospective cohort study of prognostic factors in patients with oral cavity and oropharyngeal squamous cell carcinoma 下载免费PDF全文
José F. Carrillo MD Liliana C. Carrillo MD Ana Cano MD Margarita C. Ramirez–Ortega MD PhD Jorge G. Chanona MD Alejandro Avilés MD Roberto Herrera–Goepfert MD Jaime Corona–Rivera MD Francisco J. Ochoa–Carrillo MD Luis F. Oñate–Ocaña MD 《Head & neck》2016,38(4):536-541